05 August 2024
05 August 2024
Following the FDA approval, the company plans to soft launch the Inspire V therapy system in the US later this year, with a full launch scheduled for 2025.
The acquisition brings technologies such as the G34 pen needle, and a range of pen needles to MTD’s production network.
The system’s features are expected to enhance the flexibility and precision of spinal surgeries.
The company has filed an application with the USPTO, marking the first step in commercialising its new test in the US.
DeepHRD showed superior performance compared to FDA-approved HRD diagnostics.
The PGDx elio plasma focus Dx aims to identify guideline-recommended biomarkers.
Following a US launch earlier this year, Magnus’s CEO said the company is expanding access to the therapy.
Emory will explore the feasibility of integrating the Microbot’s Liberty surgical system with an imaging system.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Per GlobalData, the US telehealth market was valued at $101.8 million in 2023. Hospitals and clinics are key distribution channels in the US telehealth market. In 2023, hospitals accounted for the largest distribution channel share of the telehealth market in the US while the telehealth software and services segment was the highest revenue contributor.
Per GlobalData, the US telehealth market was valued at $101.8 million in 2023. Hospitals and clinics are key distribution channels in the US telehealth market. In 2023, hospitals accounted for the largest distribution channel share of the telehealth market in the US while the telehealth software and services segment was the highest revenue contributor.
Per GlobalData, the US telehealth market was valued at $101.8 million in 2023. Hospitals and clinics are key distribution channels in the US telehealth market. In 2023, hospitals accounted for the largest distribution channel share of the telehealth market in the US while the telehealth software and services segment was the highest revenue contributor.
Per GlobalData, the US telehealth market was valued at $101.8 million in 2023. Hospitals and clinics are key distribution channels in the US telehealth market. In 2023, hospitals accounted for the largest distribution channel share of the telehealth market in the US while the telehealth software and services segment was the highest revenue contributor.
Per GlobalData, the US telehealth market was valued at $101.8 million in 2023. Hospitals and clinics are key distribution channels in the US telehealth market. In 2023, hospitals accounted for the largest distribution channel share of the telehealth market in the US while the telehealth software and services segment was the highest revenue contributor.
Per GlobalData, the US telehealth market was valued at $101.8 million in 2023. Hospitals and clinics are key distribution channels in the US telehealth market. In 2023, hospitals accounted for the largest distribution channel share of the telehealth market in the US while the telehealth software and services segment was the highest revenue contributor.
Give your business an edge with our leading industry insights.
